Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,11,1.01 [0.96-1.07],0.634221819190459
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,11,1.02 [0.97-1.07],0.4137607579763
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,11,1.03 [0.98-1.07],0.297528715391633
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,11,2.24 [1.27-3.92],0.0050458089436201
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,11,0.99 [0.91-1.08],0.839863244960753
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,11,1.69 [0.81-3.51],0.159421152608035
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",Inverse variance weighted,11,1.02 [0.92-1.12],0.735493847504089
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,11,1.20 [0.91-1.59],0.192532047404221
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,11,0.95 [0.66-1.36],0.765925735378857
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter II Neoplasms,Lymphoid leukaemia,Inverse variance weighted,11,0.92 [0.66-1.28],0.617845273166334
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,Inverse variance weighted,11,0.87 [0.73-1.02],0.0835124515264285
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,11,1.12 [0.86-1.47],0.405181577213315
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,11,1.01 [0.66-1.56],0.960861161552538
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,11,1.03 [0.94-1.12],0.577156447826122
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,11,1.08 [0.99-1.17],0.0780888146906207
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,Inverse variance weighted,11,1.11 [0.96-1.29],0.148408816202994
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",Inverse variance weighted,11,1.31 [1.07-1.62],0.0106555444659225
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,11,1.03 [0.90-1.19],0.651222517622987
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,11,0.92 [0.61-1.40],0.695396966883558
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,11,1.07 [0.87-1.32],0.497449412540724
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,11,1.19 [0.99-1.42],0.0614906964686398
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,Inverse variance weighted,11,1.11 [0.68-1.81],0.685760952369304
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,11,1.09 [0.98-1.21],0.0984509722274449
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,11,1.09 [0.91-1.31],0.324023916958047
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,11,1.06 [0.83-1.35],0.628884459060427
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,11,0.99 [0.89-1.10],0.846635824201091
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,Inverse variance weighted,11,0.97 [0.83-1.12],0.659900700910975
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,11,1.13 [1.00-1.29],0.0554597953879654
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,11,1.02 [0.97-1.08],0.3853384444884
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,11,1.04 [1.00-1.09],0.0708516940635924
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,11,1.13 [0.93-1.37],0.216448317757899
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,Inverse variance weighted,11,0.98 [0.83-1.15],0.789486647237898
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,11,1.02 [0.97-1.07],0.447982925933329
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,11,1.23 [1.02-1.47],0.0279386519619275
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,Inverse variance weighted,11,1.04 [0.94-1.16],0.437984837294022
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,Inverse variance weighted,11,1.03 [0.98-1.08],0.219145048174211
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,Inverse variance weighted,11,1.04 [0.99-1.08],0.144737782242595
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,Inverse variance weighted,11,0.98 [0.90-1.06],0.581606580878662
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",Inverse variance weighted,11,1.01 [0.95-1.06],0.815231094625877
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter VI Diseases of the nervous system,Parkinson's disease,Inverse variance weighted,11,1.02 [0.89-1.18],0.776386256883735
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,11,1.09 [0.97-1.24],0.147731195749855
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,11,0.94 [0.83-1.07],0.325366730940509
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,11,1.06 [0.99-1.12],0.0904873141670037
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,11,1.13 [1.07-1.20],4.52869074746843e-05
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,11,0.80 [0.67-0.95],0.0120438140458898
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,11,1.05 [0.97-1.13],0.258956098017253
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,Inverse variance weighted,11,1.05 [0.85-1.31],0.626068008720884
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,11,1.05 [0.96-1.16],0.306545651160227
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,11,1.06 [1.01-1.12],0.0206629392755571
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,11,1.07 [1.01-1.14],0.031647296121168
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,11,1.14 [0.99-1.31],0.0648908902520267
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,11,0.98 [0.94-1.02],0.388673720326358
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,11,0.98 [0.94-1.01],0.241916120474408
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,11,1.08 [0.59-1.97],0.798072414713687
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,11,0.81 [0.60-1.10],0.173376373894089
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,11,1.09 [1.04-1.14],0.000294318409497
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,11,1.05 [0.97-1.12],0.227981916716904
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,Inverse variance weighted,11,1.02 [0.83-1.26],0.850143974791257
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,11,1.04 [0.96-1.14],0.332195298132036
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,11,1.10 [0.87-1.40],0.404564034216251
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,11,1.31 [0.96-1.79],0.0870625843263029
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,Inverse variance weighted,11,0.98 [0.65-1.47],0.90588217582667
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,11,1.29 [0.95-1.74],0.0995351127019265
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,11,1.03 [0.78-1.38],0.822716398901043
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,11,1.31 [1.09-1.58],0.0044609467394119
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,11,1.42 [1.03-1.96],0.0311443401079173
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,11,1.02 [0.86-1.20],0.863685888229042
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,11,0.99 [0.95-1.03],0.571306664905282
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,11,1.04 [0.97-1.12],0.275732838951372
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,11,1.08 [1.00-1.16],0.0498443815624118
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,11,1.10 [0.94-1.28],0.240443818468274
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,Inverse variance weighted,11,1.11 [0.90-1.36],0.330695541532532
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,Inverse variance weighted,11,0.86 [0.74-1.00],0.0560981072036959
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,11,1.15 [0.97-1.36],0.107080761203854
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,11,1.13 [0.92-1.40],0.249994366822528
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,Inverse variance weighted,11,1.01 [0.92-1.12],0.812806113252845
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,11,0.90 [0.67-1.21],0.474355017394521
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,11,1.10 [0.98-1.23],0.0917083998837569
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,Inverse variance weighted,11,1.17 [0.85-1.62],0.343367835611966
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,11,1.00 [0.96-1.04],0.985596255326843
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,Inverse variance weighted,11,1.05 [0.97-1.12],0.2386413955616
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,Inverse variance weighted,11,1.06 [0.97-1.16],0.198628604001358
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,11,0.96 [0.87-1.07],0.471151382629725
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,11,0.96 [0.86-1.07],0.432768483382038
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,Inverse variance weighted,11,1.16 [0.90-1.49],0.256699556346996
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,Acute peritonitis,Inverse variance weighted,11,1.06 [0.86-1.32],0.568267823683112
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,11,0.94 [0.86-1.04],0.232817703692949
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,11,1.05 [0.94-1.18],0.367635842392999
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,11,1.02 [0.96-1.10],0.478737574730258
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,11,1.03 [0.87-1.21],0.738200035607251
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,11,0.99 [0.95-1.03],0.615076975159558
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,Inverse variance weighted,11,0.98 [0.94-1.02],0.281881063010193
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,11,0.93 [0.85-1.01],0.0882620218653118
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,11,0.97 [0.87-1.09],0.608427380482269
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,11,0.98 [0.92-1.04],0.42819475577039
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,Inverse variance weighted,11,1.21 [0.92-1.59],0.171027301065374
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,11,1.08 [0.90-1.30],0.396023998610506
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,11,0.89 [0.68-1.17],0.416497571379466
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,11,1.13 [1.02-1.25],0.0143259076268941
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,11,0.83 [0.58-1.18],0.301428292639034
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,11,1.00 [0.85-1.17],0.99731656813481
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,11,1.15 [0.96-1.37],0.123026626074258
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,Inverse variance weighted,11,1.35 [0.96-1.89],0.0849908847903219
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,Inverse variance weighted,11,1.37 [0.74-2.54],0.320799747534265
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,11,1.03 [0.97-1.09],0.368952362661236
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,11,1.17 [0.98-1.40],0.0909782678164383
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",Inverse variance weighted,11,1.15 [0.95-1.41],0.156386926269434
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,11,1.04 [0.98-1.09],0.196756639051497
EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,Inverse variance weighted,11,1.17 [0.95-1.43],0.141063073124389
